This article corrects:

  1. Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients Volume 124, Issue 10, 2341–2346, Article first published online: 18 December 2008

In the article cited above, an error was made in omitting the grant support of several organizations. The acknowledgments are as follows:

This work was supported by DC-THERA (Dendritic Cells & Novel Immunotherapies, EC 6th Framework program) and project C1 in the SFB 643 (Collaborative Research Center “Strategies of Cellular Immune Intervention” of the German Science Foundation).

We apologize to the readers for this oversight.